RNAIII-Inhibiting Peptide Affects Biofilm Formation in a Rat Model of Staphylococcal Ureteral Stent Infection-Reference-Cited by-同舟云学术

RNAIII-Inhibiting Peptide Affects Biofilm Formation in a Rat Model of Staphylococcal Ureteral Stent Infection

Published:2007-12 Issue:12 Volume:51 Page:4518-4520
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Cirioni Oscar¹,Ghiselli Roberto²,Minardi Daniele³,Orlando Fiorenza⁴,Mocchegiani Federico²,Silvestri Carmela¹,Muzzonigro Giovanni¹,Saba Vittorio²,Scalise Giorgio¹,Balaban Naomi⁵,Giacometti Andrea¹

Affiliation:

1. Institute of Infectious Diseases and Public Health, Polytechnic University of the Marche Region, A.O. Ospedali Riuniti, Ancona, Italy

2. Department of General Surgery, I.N.R.C.A.-I.R.R.C.S., Polytechnic University of the Marche Region, Ancona, Italy

3. Institute of Maternal and Children's Sciences—Urology, Polytechnic University of the Marche Region, A.O. Ospedali Riuniti, Ancona, Italy

4. Experimental Animal Models for Aging Units, Research Department, I.N.R.C.A.-I.R.R.C.S., Ancona, Italy

5. Tufts University, Cummings School of Veterinary Medicine, Department of Biomedical Sciences, North Grafton, Massachusetts 01536

Abstract

ABSTRACT Ureteral stents coated with the quorum-sensing inhibitor RNAIII-inhibiting peptide (RIP) were implanted in rat bladders and shown to suppress Staphylococcus aureus formation on the stent and in urine and was especially effective when combined with teicoplanin. Coating ureteral stents with RIP thus increases the efficacy of teicoplanin in preventing ureteral stent-associated staphylococcal infections.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00808-07

Reference17 articles.

1. Treatment of Staphylococcus aureus Biofilm Infection by the Quorum-Sensing Inhibitor RIP

2. Balaban, N., A. Giacometti, O. Cirioni, R. Ghiselli, F. Mocchegiani, Y. Gov, M. S. Del Prete, C. Viticchi, V. Saba, G. Scalise, and G. Dell'Acqua. 2003. Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. J. Infect. Dis.187:625-630.

3. Balaban, N., T. Goldkorn, Y. Gov, M. Hirshberg, N. Koyfman, H. R. Matthews, R. T. Nhan, B. Singh, and O. Uziel. 2001. Regulation of Staphylococcus aureus pathogenesis via target of RNAIII activating protein (TRAP). J. Biol. Chem.276:2658-2667.

4. Balaban, N., T. Goldkorn, R. T. Nhan, L. B. Dang, S. Scott, R. M. Ridgley, A. Rasooly, S. C. Wright, J. W. Larrick, R. Rasooly, and J. R. Carlson. 1998. Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus. Science280:438-440.

5. Balaban, N., Y. Gov, A. Bitler, and J. R. Boelaert. 2003. Prevention of Staphylococcus aureus biofilm on dialysis catheters and adherence to human cells. Kidney Int.63:340-345.

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-eluting ureteral stents: An overview;Journal of Drug Delivery Science and Technology;2024-10

2. Genomic exploration of the fermented meat isolate Staphylococcus shinii IMDO-S216 with a focus on competitiveness-enhancing secondary metabolites;BMC Genomics;2024-06-07

3. Surface modification: strategies to prevent microbial growth on medical implants;Microbial Biofilms;2024

4. Surface modification of ureteral stents: development history, classification, function, and future developments;Expert Review of Medical Devices;2023-04-12

5. New insight into old and new antimicrobial molecules targeting quorum sensing for MRSA wound infection;Future Microbiology;2022-02